AI assistant
IMMUNIC, INC. — Director's Dealing 2025
Jun 5, 2025
10196_dirs_2025-06-05_9d889189-913e-40f2-ac78-b5e7de2beac7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2025-06-04
Reporting Person: Neermann Joerg (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-04 | Common Stock | P | 70000 | $0.77 | Acquired | 170000 | Direct |
| 2025-06-05 | Common Stock | P | 30000 | $0.76 | Acquired | 200000 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7661 to $0.7730. The Reporting Person (RP) undertakes to provide to the Issuer, any securityholder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price.
F2: The purchases were made in Euros and the price was converted into U.S. dollars based on the foreign currency exchange rate as of June 4, 2025 (at Euro 1.00 = U.S. dollar 1.1384).
F3: The purchase was made in Euros and the price was converted into U.S. dollars based on the foreign currency exchange rate as of June 5, 2025 (at Euro 1.00 = U.S. dollar 1.1477).